Cargando…
Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First‐in‐Man Study
Chronic lung transplant rejection (termed chronic lung allograft dysfunction [CLAD]) is the main impediment to long‐term survival after lung transplantation. Bone marrow‐derived mesenchymal stromal cells (MSCs) represent an attractive cell therapy in inflammatory diseases, including organ rejection,...
Autores principales: | Chambers, Daniel C., Enever, Debra, Lawrence, Sharon, Sturm, Marian J., Herrmann, Richard, Yerkovich, Stephanie, Musk, Michael, Hopkins, Peter M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442848/ https://www.ncbi.nlm.nih.gov/pubmed/28186707 http://dx.doi.org/10.1002/sctm.16-0372 |
Ejemplares similares
-
Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung
por: Sinclair, Kenneth Andrew, et al.
Publicado: (2016) -
Adult human mesenchymal stromal cells and the treatment of graft versus host disease
por: Herrmann, Richard P, et al.
Publicado: (2014) -
Regional Differences in Susceptibiity of Bronchial Epithelium to Mesenchymal Transition and Inhibition by the Macrolide Antibiotic Azithromycin
por: Banerjee, Balarka, et al.
Publicado: (2012) -
Investigations into the Terminations of the Cutaneous Nerves in Man
por: Grandry,
Publicado: (1869) -
Mesenchymal Stromal Cells: Current Understanding and Clinical Status
por: Salem, Husein K, et al.
Publicado: (2010)